-
In March 2016, the FDA approved a new medication called ixekizumab (under the brand name Taltz) for the treatment of psoriatic arthritis and moderate-to-severe cases of plaque psoriasis. Ixekizumab is a biologic drug taken intravenously via injections. Biologic drugs are manufactured using living organisms in the lab. This biologic...
